Therapeutic targets in liver fibrosis. (73/548)

 (+info)

The cardiac fibroblast: functional and electrophysiological considerations in healthy and diseased hearts. (74/548)

 (+info)

Primary human colonic myofibroblasts are resistant to Clostridium difficile toxin A-induced, but not toxin B-induced, cell death. (75/548)

 (+info)

Intestinal myofibroblasts: targets for stem cell therapy. (76/548)

 (+info)

Diminished type III collagen promotes myofibroblast differentiation and increases scar deposition in cutaneous wound healing. (77/548)

 (+info)

Vitronectin accumulates in the interstitium but minimally impacts fibrogenesis in experimental chronic kidney disease. (78/548)

 (+info)

Collagen-based films containing liposome-loaded usnic acid as dressing for dermal burn healing. (79/548)

 (+info)

Outgrowth of drug-resistant carcinomas expressing markers of tumor aggression after long-term TbetaRI/II kinase inhibition with LY2109761. (80/548)

 (+info)